Fonar | 10-Q: FY2026 Q1 Revenue: USD 26.04 M

Revenue: As of FY2026 Q1, the actual value is USD 26.04 M.

EPS: As of FY2026 Q1, the actual value is USD 0.34.

EBIT: As of FY2026 Q1, the actual value is USD 3.183 M.

Manufacturing and Servicing of Medical Equipment

• Net Revenues: $2.543 million for the three months ended September 30, 2025, compared to $2.157 million for the same period in 2024.
• Cost of Sales: $1.391 million for the three months ended September 30, 2025, compared to $1.379 million for the same period in 2024.
• Operating Loss: - $1.204 million for the three months ended September 30, 2025, compared to - $1.043 million for the same period in 2024.

Management of Diagnostic Imaging Centers

• Net Revenues: $23.5 million for the three months ended September 30, 2025, compared to $22.803 million for the same period in 2024.
• Cost of Sales: $14.205 million for the three months ended September 30, 2025, compared to $13.538 million for the same period in 2024.
• Operating Income: $4.398 million for the three months ended September 30, 2025, compared to $5.649 million for the same period in 2024.

Consolidated Financial Metrics

• Total Revenues: $26.043 million for the three months ended September 30, 2025, compared to $24.960 million for the same period in 2024.
• Total Costs and Expenses: $22.849 million for the three months ended September 30, 2025, compared to $20.354 million for the same period in 2024.
• Net Income: $2.670 million for the three months ended September 30, 2025, compared to $4.000 million for the same period in 2024.
• Operating Cash Flow: $1.689 million for the three months ended September 30, 2025, compared to $1.657 million for the same period in 2024.

Future Outlook and Strategy

• Core Business Focus: The company plans to improve and expand MRI facilities managed or owned by HMCA and increase the number of scans performed at those facilities. Additionally, there is a commitment to providing enhanced equipment service and maintenance capabilities and delivering state-of-the-art equipment and upgrades at competitive prices.
• Non-Core Business: The company is considering a proposal for a going-private transaction led by its CEO and COO, which would result in the company no longer being publicly held and its common stock being de-listed from NASDAQ. This proposal is under negotiation and subject to approval by the company’s stockholders.